Difference between revisions of "File:Fig2 D'Cruz FrontCellDevBio2020 8.jpg"

From LIMSWiki
Jump to navigationJump to search
 
(Added summary.)
 
Line 1: Line 1:
==Summary==
{{Information
|Description='''Fig. 2''' Molecular structure of SARS-CoV-2 and summary of the available laboratory tests and their target molecules. SARS-CoV-2 has a lipid bilayer membrane that contains Envelope (E) and Membrane (M) proteins that make up the envelope. Spike (S) glycoproteins project from the surface of the virion. Nucleocapsid protein (N) is composed of the protein that is associated with the viral genetic material. RT-PCR, reverse transcriptase polymerase chain reaction; ELISA, enzyme-linked immunosorbent assay; LFI, lateral flow immunoassay; SVN, serum virus neutralization assay; INAA, isothermal nucleic acid amplification; CRISPR, clustered regularly interspaced short palindromic repeats; NGS, next-generation sequencing; RT-LAMP, reverse transcriptase loop-mediated isothermal amplification; RPA, recombinase polymerase amplification.
|Source={{cite journal |title=Laboratory testing methods for novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) |journal=Frontiers in Cell and Developmental Biology |author=D'Cruz, R.J.; Currier, A.W.; Sampson, V.B. |volume=8 |at=468 |year=2020 |doi=10.3389/fcell.2020.00468}}
|Author=D'Cruz, R.J.; Currier, A.W.; Sampson, V.B.
|Date=2020
|Permission=[http://creativecommons.org/licenses/by/4.0/ Creative Commons Attribution 4.0 International]
}}
== Licensing ==
== Licensing ==
{{cc-by-4.0}}
{{cc-by-4.0}}

Latest revision as of 18:12, 9 June 2020

Summary

Description

Fig. 2 Molecular structure of SARS-CoV-2 and summary of the available laboratory tests and their target molecules. SARS-CoV-2 has a lipid bilayer membrane that contains Envelope (E) and Membrane (M) proteins that make up the envelope. Spike (S) glycoproteins project from the surface of the virion. Nucleocapsid protein (N) is composed of the protein that is associated with the viral genetic material. RT-PCR, reverse transcriptase polymerase chain reaction; ELISA, enzyme-linked immunosorbent assay; LFI, lateral flow immunoassay; SVN, serum virus neutralization assay; INAA, isothermal nucleic acid amplification; CRISPR, clustered regularly interspaced short palindromic repeats; NGS, next-generation sequencing; RT-LAMP, reverse transcriptase loop-mediated isothermal amplification; RPA, recombinase polymerase amplification.

Source

D'Cruz, R.J.; Currier, A.W.; Sampson, V.B. (2020). "Laboratory testing methods for novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)". Frontiers in Cell and Developmental Biology 8: 468. doi:10.3389/fcell.2020.00468. 

Date

2020

Author

D'Cruz, R.J.; Currier, A.W.; Sampson, V.B.

Permission
(Reusing this file)

Creative Commons Attribution 4.0 International

Other versions


Licensing

File history

Click on a date/time to view the file as it appeared at that time.

Date/TimeThumbnailDimensionsUserComment
current18:09, 9 June 2020Thumbnail for version as of 18:09, 9 June 20201,081 × 566 (290 KB)Shawndouglas (talk | contribs)

Metadata